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Purpose: Apoptosis is known to play a key role in cell death after retinal ischemia. However, little is known about the
kinetics of the signaling pathways involved and their contribution to this process. The aim of this study was to determine
whether changes in the expression of molecules in the mitochondrial apoptotic pathway might explain the progression of
retinal damage following ischemia/reperfusion.
Methods: Retinal ischemia was induced by elevating intraocular pressure in the vitreous cavity to 150 mmHg for a period
of 60 min. At time 0, 3 h (early phase), and 24 h (late phase) after reperfusion, the retinas were harvested and modifications
in the expression of Bax, Bak, Bcl-2, and Bcl-xL as well as caspase-3 and −7, were examined by qPCR and, in some cases,
by western blot.
Results: qPCR analysis performed at the early phase after ischemia revealed a time dependent decrease in Bax, Bak, and
Bcl-xL and no alteration in Bcl-2 mRNA expression in response to retinal ischemia. At the protein level, proapoptotic Bax
and Bak were not modulated while Bcl-2 and Bcl-xL were significantly upregulated. At this stage, the Bax per Bcl-2 and
Bax:Bcl-xL ratios were not modified. At the late phase of recovery, Bax and Bcl-xL mRNAs were downregulated while Bak
was increased. Increased Bax:Bcl-2 and Bax:Bcl-xL ratios at both the mRNA and protein levels were observed 24 h after
the ischemic insult. Analysis of caspases associated with mitochondria-mediated apoptosis revealed a specific increase in
the expression of caspase-3 in the ischemic retinas 24 h after reperfusion, and a decrease in the expression of caspase-7.
Conclusions: This study revealed that Bcl-2-related family members were differently regulated in the early and late phases
after an ischemic insult. We showed that the Bax:Bcl-2 and Bax:Bcl-xL balances were not affected in the initial phases,
but the Bax:Bcl-xL ratio shifted toward apoptosis during the late phase of recovery. This shift was reinforced by caspase-3
upregulation.
Retinal cell death induced by transient ischemia occurs
through necrosis and apoptosis. The latter has been widely
studied. TUNEL staining has revealed that apoptotic cells can
be observed as early as 3 h after the ischemic insult and that
their number progressively increased and reached a plateau at
24 h [1-3]. These cells are mainly located in the ganglion cell
layer, the inner nuclear layer, and, to a lesser extent, the outer
nuclear layer [1,2]. In the case of moderate retinal ischemia,
as in experimental branch vein occlusion, apoptosis has also
been  observed  at  peripheral  retinal  areas  and  has  been
associated with diffuse edema of the inner nuclear layer [4].
The  mechanisms  underlying  apoptosis  following
ischemia/reperfusion  (I/R)  have  been  extensively  studied.
Special attention has been given to the mitochondria-mediated
apoptotic  pathways,  in  particular  to  the  Bcl-2  family
members, which are important regulators of cell death in the
brain, heart, liver, kidney, and retina [5-9]. This family of
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proteins is divided into proapoptotic members, including Bax,
Bak, and Bcl-2 homology domain 3 (BH3)-only proteins (i.e.,
Bad, Puma, and Noxa) and antiapoptotic members, such as
Bcl-2  and  Bcl-xL.  In  a  nonapoptotic  environment,  Bax  is
maintained in the cytosol, sequestered by the antiapoptotic
Bcl-2 and Bcl-xL [10]. When stimulated, Bax is activated and
translocated to the mitochondria, where it forms pores in the
outer  membrane  by  binding  with  the  adenine  nucleotide
translocator leading to permeabilization of the mitochondria
[11-13]. This in turn initiates cytochrome C release from the
mitochondria and activates the Apaf-1–caspase-9 apoptosome
and downstream effector caspases [14].
Increased Bax and decreased Bcl-2 expressions have been
described  in  several  models  of  cerebral  ischemia,  and  a
reduction in antiapoptotic Bcl-xL mRNA following traumatic
brain injury has also been reported [15-18]. These studies
suggest that an imbalance in the regulation between pro- and
antiapoptotic molecules triggers apoptosis. Similar studies
were performed on the retina but, excepting the consensus
observation that Bax expression was upregulated following an
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2101ischemic insult, conflicting results were obtained for Bcl-2
regulation [1,19-21].
Clarification  of  the  mechanisms  involved  in  retinal
ischemia, and a better understanding of potential similarities
between brain and retinal injury following an ischemic insult,
would serve to accelerate the development of therapies. The
aim  of  this  study  is,  therefore,  to  unravel  the  sequential
modulation of members of the Bcl-2 family following I/R in
the retina.
METHODS
Animal handling and surgery: All experimental procedures
involving rats were performed in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research and were approved by the local Committee Office
on Use and Care of Animals in Research of the State of Valais,
Sion, Switzerland.
The procedure to induce transient ischemia followed by
reperfusion has already been described [22]. In brief, 250–300
g  male  Sprague-Dawley  rats,  purchased  from  Janvier  (Le
Genest-St-Isle, France), were first anesthetized by isoflurane
inhalation and then by intraperitoneal injection of a freshly
made  mixture  of  100  mg/kg  ketamine  hydrochloride  and
10 mg/kg xylazine hydrochloride. Rat pupils were dilated with
0.5% atropine drops, and corneas were anesthetized with 2
drops of 0.4% oxybuprocain. During the whole procedure, rats
temperature was monitored and maintained at 37 °C. A steel
30-gauge  infusion  needle  (Becton  Dickinson,  Basel,
Switzerland) connected to a saline reservoir was inserted into
the vitreous cavity of the left eye. The pressure was elevated
to 150 mmHg for a period of 1 h. Retinal and choroidal
bloodstream  arrest  was  immediately  observed  under  the
binocular  microscope  Stemmi  2000-C  (Zeiss,  Feldbach,
Switzerland). After 60 min of ischemia, the pressure was
restored to normal levels by removing the needle and the
perfusion immediately resumed. The integrity of the retinal
blood  flow  was  observed  with  the  operating  binocular
microscope both before and after the procedure.
Animals were divided into a control and an I/R group.
The control group was divided into two subgroups: anesthesia
only;  and  sham-operated,  which  was  done  by  inserting  a
needle into the vitreous cavity of the rat’s left eye without
causing elevation of the intraocular pressure (IOP). In the I/R
group, the needle was inserted into the vitreous cavity of the
left  eye  and  the  pressure  increased.  At  3  or  24  h  after
reperfusion the rats were anesthetized with isoflurane and
euthanized  with  an  intraperitoneal  administration  of  an
overdose  of  150  mg/kg  bodyweight  sodium  pentobarbital
(Escarnakon; Streuli Pharma SA, Uznach, Switzerland). Both
eyes were enucleated and the retinas carefully dissected.
RNA isolation: The retinas were dissected under a binocular
microscope  to  exclude  extraretinal  tissues,  then  rapidly
isolated  in  RNAlater  (Ambion;  Applied  Biosystems,
Rotkreuz, Switzerland) before being transferred to TRIzol
reagent (Invitrogen AG, Basel, Switzerland) and stored at
−80  °C  until  RNA  extraction.  Total  RNA  was  extracted
following the manufacturer’s instructions. Both quantity and
quality  of  RNA  were  determined  on  a  ND-1000
spectrophotometer  (NanoDrop  technologies,  Inc.,
Wilmington, DE).
Quantitative  reverse  transcription-PCR:  cDNA  synthesis
was performed using 2 μg of total RNA in 20 μl reaction
volume. This was done using an oligo dT primer according to
the  manufacturer’s  manual  (Affinity  Script;  Stratagene;
Agilent  technologies  SA,  Morges,  Switzerland).  The
equivalent of 12.5 ng of original total RNA was used for
quantitative PCR amplification using the 2× brilliant SYBR
Green QPCR Master Mix (Stratagene; Agilent technologies
SA,  Morges,  Switzerland).  One  μM  forward  and  reverse
primers, designed to span an intron of the target gene were
TABLE 1. PRIMERS FOR QUANTITATIVE PCR
Gene (GenBank accession number) Primers (5′-3′) Size (bp)
Bax (NM_017059) F: GAGCGGCTGCTTGTCTGGAT 161
R: CAAGGCAGCAGGAAGCCTCA
Bak (NM_053812) F: AATGGCATCCGGACAAGGAC 135
R: TGTTCCTGCTGGTGGAGGTA
Bcl-2 (NM_016993) F: CTGAACCGGCATCTGCACAC 195
R: GCAGGTCTGCTGACCTCACT
Bcl-xL (NM_001033670) F: GGTCGCATTGTGGCCTTCTT 196
R: CTCTCGGCTGCTGCATTGTT
Casp 3 (NM_012922) F: GACTGCGGTATTGAGACAGA 209
R: CGAGTGAGGATGTGCATGAA
Casp 7 (NM_022260) F: CAACGACACCGACGCTAATC 161
R: GGTCCTTGCCATGCTCATTC
Actin-β (NM_031144) F: AGGCCAACCGTGAAAAGATG 100
R: ACCAGAGGCATACAGGGACAA
This table gives accession number, primers sequence for quantitative PCR and amplicon size.
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used  in  this  study.  Real-time  PCR  was  performed  in  a
Mx3000PTM system (Stratagene) with the following cycling
conditions:  40  cycles  of  denaturation  at  95  °C  for  30  s,
annealing at 59 °C for 30 s, and extension at 72 °C for 30 s.
Samples  were  amplified  in  triplicate,  and  data  were
normalized with expression of β-actin.
Western blot analysis: The retinas were rapidly dissected in
1×  phosphate-buffered  saline  (PBS;  NaCl  137  mM,  KCl
2.7  mM,  Na2HPO4  10  mM,  KH2PO4  1.75  mM,  pH  7.4)
Figure 1. Ischemia reduced Bax, Bak, and Bcl-xL mRNAs expression
3 h after I/R. Bax (A), Bak (B), Bcl-2 (C), and Bcl-xL (D) mRNAs
expression was measured by qPCR 3 h after reperfusion. At 3 h after
reperfusion, ischemia decreased Bax (A), Bak (B), and Bcl-xL (D)
expression but did not alter the Bcl-2 mRNA level (C). E and F
showed no modification in Bax:Bcl-2 nor Bax:Bcl-xL mRNA ratios
in the early phase after I/R. Brown columns denote control retinas
(n=6), and beige columns denote ischemic retinas (n=10). Error bars
represent  SEM,  where  *p<0.05,  ***p<0.001  in  control  versus
ischemic retinas as measured by Student's t-test.
supplemented with a 1× protease inhibitor cocktail (Roche
Applied  Science,  Basel,  Switzerland).  Retinas  were  then
transferred  to  a  Hepes-Tween  solution,  which  contained
20  mM  Hepes  and  0.5%  Tween-20,  and  included  1×
phosphatase  and  1×  protease  inhibitor  cocktails  (Sigma-
Aldrich,  Basel,  Switzerland),  before  they  were  stored  at
−80 °C until protein extraction. Samples were frozen and
thawed three times, then homogenized on ice. Supernatant
was collected after 30 min of centrifugation at 9.3 xg at 4 °C.
The amount of protein was determined using a bicinchoninic
acid  (BCA)  protein  assay  kit  (Pierce  Biotechnology,
Rockford, IL). As loading control, β-actin was measured in
each western blot. Protein samples were run on 12% SDS–
PAGE and transferred to a polyvinylidene fluoride membrane
(Whatman; Schleicher and Schuell, St. Marcel, France) for 1
h at 4 °C. Membranes were then blocked at room temperature
for 1 h in 1× tris-buffered saline (TBS; NaCl 137 mM, TRIS
25 mM, pH 7.4) and 0.1% Tween-20 and incubated with the
appropriate  antibody  overnight  at  4  °C.  Antibodies  were
diluted  in  1×  TBS  and  0.1%  Tween-20  containing  2%
blocking reagent (ECL Advanced; Amersham Biosciences,
Otelfingen,  Switzerland).  Next,  1:1,000  rabbit  anti-Bcl-2
(#2876), 1:1,000 anti-Bcl-xL (#2764), and 1:1,000 anti-Bak
(#3814)  were  obtained  from  Cell  Signaling  Technology
(Bioconcept, Alschwill, Switzerland), rabbit anti-Bax (#493)
from Santa Cruz Biotechnology (LabForce AG, Nunnigen,
Switzerland) and 1:10,000 mouse anti-β-actin (#A5441) from
(Sigma-Aldrich,  Basel,  Switzerland).  Detection  was
performed with horseradish peroxidase-conjugated secondary
antibodies (Amersham Biosciences; Otelfingen, Switzerland)
and visualized by enhanced chemiluminescence (Millipore
Corporation, Billerica, MA,) on a luminescent image analyzer
(LAS  4000mini;  Bucher  Biotech,  Basel,  Switzerland).
Quantification analysis of the proteins was performed with
Multigauge (Fujifilm) software.
Statistics: Results are presented as mean ±standard error of
the  mean  (SEM)  of  the  indicated  number  of  independent
experiments.  Statistical  analysis  was  performed  using  the
Student’s t-test. Differences were considered significant for
p<0.05.
RESULTS
To unravel the mechanisms involved in the apoptotic process
induced after retinal ischemia, we assessed whether members
of the Bcl-2 family of genes were regulated early (3 h) or late
(24 h) after I/R, both at the mRNA and protein levels. As our
preliminary experiments indicated that both anesthesia and
sham-insertion  of  a  needle  in  the  vitreous  cavity  were
associated  with  modulation  of  several  of  the  genes
investigated, we compared each measurement with values
from sham-operated rats set to 1.
Early modulation at mRNA level: Three hours after I/R,
the following proapoptotic Bax (0.679±0.058, p<0.05) and
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antiapoptotic Bcl-xL (0.768±0.047, p<0.05) were significantly
downregulated.  The  antiapoptotic  Bcl-2  did  not  change
(0.868±0.169;  Figure  1A-D).  Rather  than  individual  gene
alteration,  it  is  the  ratio  between  pro-  and  antiapoptotic
members  that  is  responsible  for  cell  fate.  We  therefore
calculated the Bax:Bcl2 and Bax:Bcl-xL ratios in each retina,
but  neither  ratio  showed  any  alteration  3  h  after  I/R
(0.940±0.205 and 0.996±0.113, respectively; Figure 1E-F).
Early modulation at protein level: At the protein level,
Bcl-2 and Bcl-xL increased 3 h after I/R (1.446±0.163, and
1.697±0.294,  respectively)  while  Bax  and  Bak  levels
increased  slightly  but  not  significantly  (1.171±0.136,
1.769±0.531; Figure 2A-D). As for mRNA, the Bax:Bcl-2 and
Bax:Bcl-xL  protein  ratios  did  not  reveal  any  modulation
(1.144±0.238 and 0.970±0.129, respectively; Figure 2E-F).
Late modulation at mRNA level:: Analyses 24 h post I/R
revealed  that  Bax  and  Bcl-xL  were  downregulated
(0.841±0.033,  p<0.05,  and  0.604±0.025,  p<0.01,
respectively)  while  Bak  was  upregulated  (1.478±0.052,
p<0.001; Figure 3A-B,D). The strong decline of Bcl-xL was
further  amplified  in  the  Bax:Bcl-xL  ratio  (1.446±0.106;
Figure 2. Ischemia did not modify proapoptotic but increased antiapoptotic proteins 3 h after I/R. Effect of ischemia 3 h after reperfusion on
Bax (A), Bak (B), Bcl-2 (C), Bcl-xL (D) protein levels measured by western blot. In (E-F) no modification in Bax/Bcl-2 nor Bax/Bcl-xL protein
ratios were observed at this time. Brown columns denote control retinas (n=6–10), and beige columns denote ischemic retinas (n=8–12). Error
bars represent SEM, where *p<0.05 in control versus ischemic retinas as measured by Student's t-test.
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(0.759±0.116),  nor  was  the  Bax:Bcl-2  ratio  (1.194±0.132,
Figure 3C,E).
Late modulation at protein level: Contrary to mRNA,
Bax and Bcl-xL protein levels were significantly upregulated
24  h  post  I/R  (1.511±0.148  and  1.402±0.188,  p<0.05,
respectively). The strong upregulation seen for Bak at the
mRNA  level  was  not  present  at  the  protein  level
Figure 3. mRNA levels of Bak increased and Bcl-xL decreased 24 h
after I/R. Bax (A), Bak (B), Bcl-2 (C), and Bcl-xL (D) mRNAs
expression was measured by qPCR 24 h after reperfusion. Twenty-
four h after reperfusion, ischemia induced a slight decrease in Bax
(A), and strongly increase Bak (B) mRNA expression. Anti-apoptotic
Bcl-2 expression (C) was not modified, but Bcl-xL (D) was strongly
reduced 24 h after I/R. Figure 1 E,F revealed no modification in
Bax:Bcl-2 and a highly significant increase in Bax:Bcl-xL mRNAs
ratio 24 h after I/R. Brown columns denote control retinas (n=6), and
beige columns denote ischemic retinas (n=10). Error bars represent
SEM, where *p<0.05, **p<0.005, ***p<0.001 in control versus
ischemic retinas as measured by Student's t-test.
(1.270±0.177).  Bcl-2  protein  did  not  change  significantly
(1.447±0.217). The shift of balance toward apoptosis was also
evident on the Bax:Bcl-2 and Bax:Bcl-xL ratios (1.463±0.216,
1.340±0.165; p<0.05; Figure 4A-F).
We then focused on the kinetics of the response and
compared  the  modulation  of  the  Bcl-2  family  members
between the early (3 h) and late (24 h) phases post I/R. Bax
expression significantly increased by about 30% both at the
mRNA (1.325±0.044) and protein levels (1.383±0.135), while
Bcl-xL decreased by about 20% at the mRNA (0.787±0.033)
and protein levels (0.826±0.106). Bak was upregulated at the
mRNA level (2.462±0.103) but this was not confirmed at the
protein  level  (0.717±0.387).  Here  again,  these  seemingly
small  modifications  of  expression  were  further  amplified
when the Bax:Bcl-xL ratio was analyzed, and a strong shift of
the  pro-  and  antiapoptotic  balance  toward  apoptosis  was
observed. Interestingly, Bcl-2 did not seem to be involved in
the kinetics of the response to I/R because it did not change
significantly (Figure 5).
Ischemia-induced  caspase-3  and  repressed  caspase-7
mRNAs expression 24 h after I/R: To further investigate the
impact  of  retinal  ischemia  on  downstream  effectors  of
apoptosis stimulated by members of the Bcl-2 family, we
analyzed the expression of caspase-3 and caspase-7 by qPCR.
In  the  early  recovering  phase,  caspase-3  did  not  change
(1.147±0.077)  and  caspase-7  was  downregulated
(0.646±0.052).  At  24  h  post  I/R,  caspase-7  was  further
reduced  (0.536±0.025,  p<0.005)  while  caspase-3  was
upregulated (1.656±0.141, p<0.05) (Figure 6A-D). Kinetics
analysis of caspase regulation revealed a strong increase in
caspase-3  expression  (1.494±0.128,  p<0.005)  and  no
modulation of caspase-7 (0.830±0.039; Figure 6E-F).
DISCUSSION
Artificial  IOP  increase  is  a  recognized  model  of  retinal
ischemia and is accompanied by apoptosis. We and other
researchers have observed in this model that the number of
dying cells increases from 3 h (early) until 24 h (late) after I/
R [3]. In this study, we analyzed the response of several
Bcl-2-related genes in an early and late period following I/R.
We first considered the regulation of several Bcl-2 family
genes at time 0, 3, and 24 h in control retinas from anesthetized
animals and from anesthetized animals in which a needle had
been inserted and kept in place for 1 h, but without initiating
any increase in IOP. We observed that the sole insertion of a
needle triggered upregulation of several genes. Therefore, and
to specifically track the changes induced by ischemia rather
than by anesthesia or needle insertion, we compared gene
regulation between ischemic and needle inserted-only retinas.
Our  results  showed  a  dysregulation  between  pro-  and
antiapoptotic  genes  resulting  in  a  proapoptotic  signaling
cascade in ischemic retinas. This underlined the importance
of a time-related upregulation of the proapoptotic Bax and did
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The injury is mostly due to Bcl-xL downregulation rather than
downregulation  in  Bcl-2  expression.  Although  slight
differences  between  mRNA  and  protein  regulation  were
obtained  in  ischemic  and  control  retinas,  Bax:Bcl-2  and
Bax:Bcl-xL  ratios  were  similarly  modulated  over  time.
Upregulation of Bax at the protein level is in agreement with
in vitro and in vivo studies of retinal ischemia [1,19-21] as
well as observations made after cerebral ischemia [15-17].
However,  we  demonstrated  that  Bax  mRNA  and  protein
increase is time dependent, suggesting a delayed role for this
gene in the apoptotic process induced by I/R.
The regulation of Bcl-2 has widely been considered in the
study of the retina as well as in cerebral ischemia. In the central
nervous system, however, the role of Bcl-2 in response to
neuronal  injury  is  unclear  because  both  increases  and
decreases in Bcl-2 levels have been described. In vitro, a
decrease  in  the  expression  of  Bcl-2  has  been  reported  in
Figure 4. Ischemia induced a protein imbalance toward apoptosis 24 h after the ischemic insult. Bax (A), Bak (B), Bcl-2 (C), and Bcl-xL
(D) protein levels were measured by western blot 24 h after I/R. At this time proapoptotic Bax was significantly increased (A), but there was
no modification in Bak (B). No modification in Bcl-2 (C) and an increase in Bcl-xL (D) protein levels were observed 24 h after reperfusion. In
E and F, a significant increase in Bax:Bcl-2 and Bax:Bcl-xL protein ratios were measured at this time. Brown columns denote control retinas
(n=6–10) and beige columns denote ischemic retinas (n=8–12). Error bars represent SEM, where *p<0.05, **p<0.005 in control versus
ischemic retinas as measured by Student's t-test.
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simulated  ischemia  and  excitotoxicity  [19],  whereas  no
obvious change in Bcl-2 gene expression was observed in vivo
in retinas where ischemia was induced by increased IOP [1].
In another report, retinal ischemia was shown to induce an
initial decrease in Bcl-2 mRNA expression followed by a later
increase in its expression [21]. The discrepancies of the results
reported on Bcl-2 expression are reinforced by the observation
that  Bcl-2  peptide  administration  did  not  increase  retinal
ganglion cell survival after optic nerve section but did so after
selective  ligature  of  the  ophthalmic  vessels  [23].  Clearly,
Bcl-2 involvement is not identical in these different models.
In our study, we showed an increase of this protein during the
early  phase  following  I/R,  after  which  its  level  remained
constant until at least 24 h. This observation is in accordance
with the results obtained by Kaneda et al. [1] at the mRNA
level.
Bcl-2 has also been assessed in the experimental model
of glaucoma after hypertonic saline injection [24]. In this
study, the increase of apoptosis in retinal ganglion cells was
linked to a downregulation of the Bcl-2:Bax ratio. However,
this decrease was associated with a marked reduction in Bcl-2
rather than with an increase in Bax itself [24]. The difference
in  the  role  of  Bcl-2  in  our  study  could  result  from  the
experimental model and from the duration of the experiment.
Furthermore, our results do not exclude Bcl-2 downregulation
after 24 h.
A mRNA study of Bcl-xL regulation after I/R revealed that
it was slightly but significantly downregulated in comparison
to sham-operated retinas. Consistent with mRNA and protein
regulation was the time-dependent downregulation of Bcl-
xL. Our results are in agreement with the moderate decrease in
Bcl-xL mRNA expression in the retina observed after optic
nerve  crush  [25].  The  observation  that  Bcl-xL  is  the
predominant Bcl-2 family member expressed in the retina
supports the concept that the neural retina has a pattern of
Bcl-2 expression similar to that of other central neurons [25,
26]. This suggests that modification in Bcl-xL expression after
I/R in the retina could be identical to that following cerebral
ischemia.  However,  our  results  showing  a  time-related
decrease in Bcl-xL expression in the retina following I/R are
in conflict with a publication on hippocampal neurons, where
no  alteration  of  the  abundance  of  Bcl-xL  was  observed
following I/R [27].
The  observation  that  neither  the  Bax:Bcl-2  nor  the
Bax:Bcl-xL ratios are regulated at a time when apoptosis is
already detectable (3 h) suggests that Bcl-2-related family
members are not associated with early cell death following I/
R.  However,  the  number  of  apoptotic  cells  may  not  be
sufficient to allow for an accurate reading of the contribution
of Bcl-2 family members. An alternative explanation could be
that apoptosis is triggered not by an increase in Bax expression
but  by  its  translocation  to  the  mitochondria,  as  has  been
demonstrated in a central retinal artery occlusion model of
retinal  ischemia  [2].  More  investigations  regarding  the
activity of Bax are needed to attest Bcl-2 involvement in the
deleterious effect induced by an ischemic insult of the retina.
Bak, another member of the Bcl-2 family, has been shown
to change its intracellular location early in the promotion of
apoptosis [28]. In comparison to Bax- or Bak-deficient mice,
Bax  and  Bak  double  knockout  mice  displayed  multiple
developmental defects, including an accumulation of excess
cells within the central nervous system. This indicated that
both Bax and Bak have overlapping roles in the regulation of
apoptosis  during  mammalian  development  and  tissue
Figure 5. Bcl-2 family members are similarly regulated at the mRNA and protein levels. Ischemia modified Bax, Bak, Bcl-2, and Bcl-xL
mRNA (A) and protein expression (B) 24 h after reperfusion relative to 3 h. A: Proapototic Bax and Bak mRNAs expression was increased,
whereas antiapoptotic Bcl-xL was decreased and Bcl-2 expression unaltered 24 h after I/R. B: At the protein level, Bax expression was
significantly increased but there was no modification in Bak, Bcl-2, or Bcl-xL when measured 24 h after I/R. Green columns mark ischemic/
ctrl ratio (i/c) ratio at 3 h, and light blue columns indicate i/c ratio at 24 h. Error bars represent SEM, where *p<0.05, ***p<0.001 in control
versus ischemic retinas as measured by Student's t-test.
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2107homeostasis  [29].  In  the  same  way,  Bax  and  Bak  double
knockout cells showed resistance to apoptosis induced by
various  stimuli,  demonstrating  the  crucial  role  of  these
Figure  6.  Ischemia  induced  caspase-3  and  repressed  caspase-7
mRNAs expression 24 h after reperfusion. Caspase-3 (A-C) and
caspase-7 (B-D) mRNAs expression was measured by qPCR 3 h
(A-B) and 24 h (C-D) after reperfusion. A-B: No change in caspase-3
(A) or caspase-7 (B) was observed 3 h after I/R. C-D: Ischemia
induced  a  significant  increase  in  caspase-3  (C)  and  decrease  in
caspase-7  (D)  mRNA  24  h  following  the  ischemic  insult.  E:
Ischemic/ctrl ratio (i/c) mRNA ratios reported an important increase
in caspase-3 and no changes in caspase-7 between 3 and 24 h after
I/R.  Brown  columns  mark  control  retinas  (n=6–10),  and  beige
columns denote ischemic retinas (n=8–12). Green columns represent
i/c ratio at 3 h, and light blue columns indicate i/c ratio at 24 h. Error
bars represent SEM, where *p<0.05, **p<0.005 in control versus
ischemic retinas, and #p<0.01 ischemic retinas at 3 h versus 24 h as
measured by Student's t-test.
proteins in the regulation of cell death [11]. However, a 2006
study underlined the role of Bax and Bak in the regulation of
mitochondrial dynamics in healthy cells and indicated that
Bcl-2 family members may also regulate apoptosis through
organelle  morphogenesis  [30].  Bax  and  Bak  were  also
reported to act as essential components of the unfolded protein
response.  Although  this  role  is  independent  of  their
proapoptotic function, it appeared that Bax and Bak might act
as  stress  sentinels  that  connect  stress  signals  to  the
proapoptotic core when cellular homeostasis is irreversibly
altered [31].
As these different studies support a major role for Bak in
the regulation of apoptosis, we also analyzed its expression
by  quantitative  PCR  and  western  blot.  Surprisingly,  our
results  showed  that  Bak  regulation  does  not  play  a
fundamental  role  in  apoptosis  following  retinal  ischemia.
Indeed, even if its mRNA expression was time-dependently
regulated,  the  observation  that  it  was  not  altered  by  the
ischemic insult at the protein level suggested that Bak level
was not crucial to the apoptotic event following I/R at the time
studied. However, the analysis of Bak expression later than
24 h after I/R could also reveal an important role of this
protein. Furthermore, the absence of Bak protein regulation
did not exclude that its apoptotic effect could be induced by
its translocation rather than by its regulation after I/R, but this
remains to be demonstrated [28].
Bax and Bak activation, opening of the mitochondrial
permeability transition pore (mPTP), and cell death have been
reported  to  be  mediated  through  Bcl-2/adenovirus  E1B
19 kDa protein-interacting protein 3 (Bnip3), a BH3-only
protein localized primarily in mitochondria [32-34], although
this  is  still  controversial  [35].  In  a  model  of  myocardial
ischemia  and  reperfusion,  Bnip3  was  reported  as  a
mitochondrial  sensor  of  oxidative  stress  [36],  thus
contributing to cell death during I/R in ex vivo-perfused hearts
and in cell culture [37,38]. Therefore, it would be interesting
to study Bnip3-induced activation of Bax and Bak and to
analyze whether Bnip-3 could also be associated with the
increase  in  apoptosis  observed  after  I/R  in  the  retina.
However, preliminary results more readily suggest a decrease
in Bnip-3 expression after I/R. Bellot et al. very recently
demonstrated that hypoxia induced autophagy via Bnip-3 and
that  Bnip-3L  was  clearly  a  survival  mechanism  [39].
However, these observations were not in accordance with
Puyal  et  al.  [40],  whose  work  revealed  that  cerebral
postischemic  autophagy  inhibition  was  neuroprotective.
Further  studies  are  needed  to  resolve  this  issue  and  to
determine the proapoptotic or prosurvival action of Bnip-3
expression.
We also showed that caspase mRNA was specifically
modulated by ischemia, as we reported a time-related increase
in caspase-3 and decrease in caspase-7. Caspase-3, a well
known apoptosis effector, has been studied in several models
Molecular Vision 2009; 15:2101-2110 <http://www.molvis.org/molvis/v15/a226> © 2009 Molecular Vision
2108of  retinal  ischemia,  including  IOP  elevation  [41-43]  and
axotomy  [44-46].  Caspase-7,  which  is  structurally  and
functionally  similar  to  caspase-3,  has  been  shown  to
compensate for the lack of caspase-3 [47,48]. Therefore, it
seems likely that the absence of caspase-7 upregulation is a
consequence of the regulation of caspase-3.
In summary, the current study reports a novel regulation
of Bcl-2-related family members following retinal ischemia.
It clearly finds an association with an increase in Bax with a
decrease in Bcl-xL expression and negates any involvement of
Bak and Bcl-2 regulations in the damage induced by retinal
ischemia 24 h after reperfusion. It also links caspase-3 to the
deleterious effect induced by the elevation of IOP. Finally,
although further investigations will be necessary to unravel
the  exact  mechanism  involved  following  I/R,  this  study
highlights the importance of mitochondrial mediation of the
apoptotic pathway in the deleterious effects in this model.
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